All these findings considered, we speculate that tumor cells benefit from NK cells expressing CXCR4 and S1PR5 in two ways: retaining NK cells in the tumor periphery and desensitizing NK cells to stimulation before they reach the tumor stroma. Here, CXCR4 is linked to neoplasm.